跳至主要内容
临床试验/CTRI/2025/03/082116
CTRI/2025/03/082116尚未招募不适用

A clinical study on Kasa roga in children with Balachaturbhadra churna

Dr Urmila Bariha1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年3月24日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To reduce the classical symptoms of Kasa and study the efficacy of drug Balachaturbhadra churna.

研究概览

简要总结

Respiratory complaints are well defined condition in medical science and cough is the most common complain among them.Kasa roga seems to be very simple disease but if it is neglected or mismanaged it may result in disease with poor prognostic condition. The drug Balachaturbhadra churna has maximum ingredients having  kapha-pitta samaka  properties and also tetracyclic triterpenes,Tannic acid of karkatashringi & ativisa has antioxidant properties, rotundone of Musta have anti-inflammatory, hepatoprotective, anti-pyretic properties, Pippali has many properties, including being acrid, stimulant, appetizer,anti-oxidant, and anti-tussive,that helps in easy expectoration. Thus, I expect Balachaturbhadra churna may be helpful in curing the disease and will be beneficial to society.

研究设计

研究类型
Observational

入排标准

年龄范围
4.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Patients presenting with signs and symptoms of vataja, pittaj and kaphaja kasa roga.
  • Those who have not received any medication for cough and cold in last 24 hours.

排除标准

  • 1-patient less than 4 year of age & above 12 year.
  • 2-khsyataja and khsyaja kasa 3- kasa associated with fever, bronchial asthma, TB, severe lower RTI.
  • 4- History of malignancy or any other congenital, anatomical abnormalities of chest & respiratory system.
  • 5-kasa associated with severe malnutrition 6- kasa associated with neurological disorder.

结局指标

主要结局

To reduce the classical symptoms of Kasa and study the efficacy of drug Balachaturbhadra churna.

时间窗: 14 days

次要结局

  • To reduce the classical symptoms of Kasa roga.(14 days)

研究者

发起方
Dr Urmila Bariha
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验